AbbVie shares, which hit a 52-week high in late October after the drugmaker posted quarterly earnings that topped Wall Street's expectations and raised its dividend by nearly 6%, were recently down ...

AbbVie added emraclidine via the approximately $8.7 billion acquisition of Cerevel Therapeutics. The program also includes an ...

E-commerce company Shopify (SHOP) is set to report its third quarter earnings results on Tuesday, November 12th, before the ...

This will be a strong overall net benefit, however, given the company's history on membership fee increases ... At the end of ...

BioLife Solutions Inc (NASDAQ:BLFS) is set to release its Q3 2024 earnings on Nov 12, 2024. The consensus estimate for Q3 ...

Dividend amount and dividend per share are quoted in the currency of the stock selected. Please note that past performance is not a reliable indicator of future returns. Important Information Please ...